Healthcare & Life Sciences
OMass Therapeutics
United Kingdomomasstx.com
OMass Therapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C+, 4 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2016
Founded
4
Investors
About OMass Therapeutics
OMass Therapeutics is a company founded in 2016 headquartered in the United Kingdom. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics using a proprietary discovery platform that leverages mass-spectrometry-enabled approaches to identify and optimize ligands for challenging protein targets.
Explore OMass Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.